An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment

NCT00526877 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorders

Interventions

DRUG: Risperidone

Sponsor

Johnson & Johnson Taiwan Ltd